⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 23 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 50 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 23 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 50 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine AT January 20, 2026

Quetiapin +pharma 300 mg Filmtabletten (Filmtablette)

📷 Wikipedia: Quetiapine · Source
Quetiapin +pharma 300 mg Filmtabletten (Filmtablette)
📷 Wikipedia: Quetiapine · Source
Quetiapine 300 mg film-coated tablets Reason: manufacturing delay Marketing authorisation holder: +pharma Arzneimittel GmbH, Hafnerstraße 211, 8054 Graz, Austria Affected packs: 60-tablet box, blister pack [not available since 27 January 2026, resupply 26 May 2026]; 30-tablet box, blister pack [not available since 20 January 2026, resupply 26 May 2026]
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 239 days ago.
📈 Timeline
15 days in total
May 18, 2026 June 2, 2026

What is this? Quetiapin is a medicine used to treat mental health problems. It comes as 300 mg tablets.

What's happening? There is a delay in making these tablets. Some packs are not available now.

Does this affect me? If you take this medicine in Austria, you may have trouble finding it.

What should I do? Ask your pharmacist or doctor for advice before changing anything.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: N05AH04 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: +pharma Arzneimittel gmbh, Hafnerstraße 211, 8054 Graz, Österreich · Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-01-27, resupply 2026-06-09] · 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-01-20, resupply 2026-06-09]

First published
January 20, 2026
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Quetiapin +pharma 300 mg Filmtabletten (Filmtablette). Quetiapine 300 mg film-coated tablets Reason: manufacturing delay Marketing authorisation holder: +pharma Arzneimittel GmbH, Hafnerstraße 211, 8054 Graz, Austria Affected packs: 60-tablet box, blister pack [not available since 27 January 2026, resupply 26 May 2026]; 30-tablet...
When was this alert issued?
This alert was issued on January 20, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.